Skip to main content
BDMD
NASDAQ Industrial Applications And Services

Baird Medical Reports Significant 2025 Net Loss and Revenue Decline Amid Soaring Expenses and Liquidity Concerns

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Negative
Importance info
9
Price
$1.87
Mkt Cap
$67.576M
52W Low
$0.757
52W High
$7.262
52W Position info
147% above low
Off High info
74% below high
Rel. Volume info
0.1× avg
Market data snapshot near publication time

BDMD has more than doubled off its 52-week low of $0.757 on light trading volume (0.1× avg).

Summary

Baird Medical reported a substantial net loss and a significant revenue decline in 2025, driven by soaring operating expenses and critically low cash, raising serious liquidity and operational concerns.


Key Events · Earnings and Guidance · BDMD

  • Significant Financial Deterioration

    The company swung from a net income of $12.6 million in 2024 to a net loss of $27.5 million in 2025. Total revenues decreased by 39.2% from $37.0 million in 2024 to $22.5 million in 2025.

  • Soaring Operating Expenses

    Total operating expenses increased by 157% from $17.3 million in 2024 to $44.5 million in 2025. Research and development expenses alone surged by 224% to $20.1 million in 2025, attributed to FDA/CE certification and AI ablation systems.

  • Critical Liquidity Position

    Cash and restricted cash plummeted from $2.97 million in 2024 to $0.56 million in 2025. Net cash used in operating activities was $1.3 million in 2025. The company secured additional short-term loans totaling approximately $3.2 million in early 2026, indicating ongoing liquidity needs.

  • High Overdue Accounts Receivable

    As of December 31, 2025, $23.2 million of accounts receivable were overdue by more than one year, representing a significant portion of total receivables and posing a risk to future cash flow.


Analysis · BDMD · Industrial Applications And Services

Baird Medical Investment Holdings Ltd's 2025 annual report reveals a severe deterioration in financial performance, with a substantial swing from net income to a significant net loss. Revenue declined sharply, while operating expenses, particularly R&D, surged. The company's cash position is critically low, and a large portion of its accounts receivable is overdue, raising significant liquidity concerns. The disclosure of material weaknesses in internal controls and a recent auditor change further highlight operational and compliance risks. While the company is investing heavily in R&D for future growth, the immediate financial results indicate a challenging period ahead, with ongoing reliance on external financing.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 52.4% of the 208 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -1.91%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDMD was trading at $1.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $67.6M. The 52-week trading range was $0.76 to $7.26. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDMD - Latest Insights

BDMD
Nov 16, 2026, 4:30 PM EST
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.0924
Real-time Price: $0.0812 info
Change: -$0.0112 (-12%) info
Market Cap: $2.627M info
BDMD
Nov 04, 2026, 4:45 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $0.1034
Real-time Price: $0.0812 info
Change: -$0.0222 (-21%) info
Market Cap: $2.627M info
BDMD
Nov 02, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $0.1502
Real-time Price: $0.0812 info
Change: -$0.069 (-46%) info
Market Cap: $2.627M info
BDMD
Sep 30, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $0.780
Real-time Price: $0.0812 info
Change: -$0.6988 (-90%) info
Market Cap: $2.627M info
BDMD
Sep 30, 2026, 7:18 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.7725
Real-time Price: $0.0812 info
Change: -$0.6913 (-89%) info
Market Cap: $2.627M info